CALCIPOTRIENE 0.005% / CLOBETASOL PROPIONATE 0.05%- calcipotriene 0.005% / clobetasol propionate 0.05% solution 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

CALCIPOTRIENE 0.005% / CLOBETASOL PROPIONATE 0.05%

Directions for use

sd

Sincerus Florida, LLC. Adverse reactions

fsf

Active, inactive

cs

NDC 72934- 4029-5 CALCIPOTRIENE USP 0.005% / CLOBETASOL PROPIONATE USP 0.05%. Solution 60 gm

sd

CALCIPOTRIENE 0.005% / CLOBETASOL PROPIONATE 0.05% 
calcipotriene 0.005% / clobetasol propionate 0.05% solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-4029
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CALCIPOTRIENE (UNII: 143NQ3779B) (CALCIPOTRIENE - UNII:143NQ3779B) CALCIPOTRIENE0.005 g  in 100 g
CLOBETASOL PROPIONATE (UNII: 779619577M) (CLOBETASOL - UNII:ADN79D536H) CLOBETASOL PROPIONATE0.05 g  in 100 g
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-4029-560 g in 1 CYLINDER; Type 0: Not a Combination Product05/20/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/20/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-4029)

Revised: 5/2019
Document Id: 8957fab8-eca1-2494-e053-2995a90a6c29
Set id: 8957fab8-eca0-2494-e053-2995a90a6c29
Version: 1
Effective Time: 20190520
 
Sincerus Florida, LLC